Skip to main
IRWD
IRWD logo

Ironwood Pharma (IRWD) Stock Forecast & Price Target

Ironwood Pharma (IRWD) Analyst Ratings

Based on 26 analyst ratings
Hold
Strong Buy 27%
Buy 8%
Hold 62%
Sell 0%
Strong Sell 4%
Ironwood Pharma (IRWD) has been analyzed by 26 analysts, with a consensus rating of Hold. 27% of analysts recommend a Strong Buy, 8% recommend Buy, 62% suggest Holding, 0% advise Selling, and 4% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ironwood Pharma and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ironwood Pharma (IRWD) Forecast

Analysts have given Ironwood Pharma (IRWD) a Hold based on their latest research and market trends.

According to 26 analysts, Ironwood Pharma (IRWD) has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.05, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.05, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ironwood Pharma (IRWD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.